Automated breast ultrasound detects significantly more invasive cancers in dense breasts

Chalfont St. Giles, UK – September 22, 2016 – The Automated Breast Ultrasound (ABUS) system is found to have significantly improved cancer detection in women with dense breast tissue when used together with mammography.  The European Asymptomatic Screening Study aimed to evaluate the impact of ABUS in conjunction with full field digital screening mammography (FFDSM)... Read more

GE Healthcare’s Biosafe announces Sefia platform to address multiple steps in cell therapy production process

CHALFONT ST. GILES, UK – 30 September 2016 –At the International Society for Cellular Therapy’s Regional Meeting in Memphis, TN, GE Healthcare’s recently acquired Biosafe Group introduces Sefia, a state-of-the-art, multi-function platform which uses a combination of continuous-flow centrifugation, temperature control and fluidic management to enable purification, concentration, washing  and final formulation during cell processing. Combined with GE... Read more

GE Healthcare opens USD 7.4 million APAC Fast Trak Bioprocessing Technology and Training Center in South Korea

Chalfont St. Giles, UK and Songdo, Korea – 29 September 2016 – GE Healthcare’s Life Sciences business, a global provider of technologies and expertise to the biopharmaceutical and life sciences industries, announced today the opening of a GE Fast Trak Center in Songdo, Incheon Metropolitan City, South Korea. The new USD 7.4 million Center will... Read more

New, reliable and affordable method for glyphosate analysis presented

Metrohm is pleased to present an application for the straightforward determination of the herbicide glyphosate and its primary metabolite AMPA in drinking water by ion chromatography with pulsed amperometric detection. With a detection limit of approximately 1 µg/L, the method is sensitive enough to comply with limit values in the US, Canada, Australia, and others.... Read more

Cellular Dynamics International Launches Opsis Therapeutics to Develop Cell Therapies for Treatment of Retinal Diseases

Cellular Dynamics International Launches Opsis Therapeutics to Develop Cell Therapies for Treatment of Retinal Diseases MADISON, WIS, September 28, 2016 – Cellular Dynamics International, Inc. (CDI), a FUJIFILM company and the leading developer and manufacturer of induced pluripotent stem cell (iPSC) products, today announced a new venture, named Opsis Therapeutics. Formed on July 31, Opsis Therapeutics... Read more

Cellular Dynamics Announces Launch of iCell® Hepatoblasts to Enable Research into Therapies That Stimulate Liver Regeneration

MADISON, Wis., September 22, 2016 – Cellular Dynamics International, Inc. (CDI), a FUJIFILM company, today announced the launch of iCell® Hepatoblasts, liver progenitor cells generated from human induced pluripotent stem cells (iPSCs). These cells show promise for liver regeneration therapy research by enabling researchers to identify molecules capable of stimulating liver progenitor cell proliferation and... Read more

See. Click. Send. New Cloud-based Ultrasound Solution Enables Instant, Enhanced Collaboration Among Clinicians

Rome – 22 September 2016 – GE Healthcare and Trice Imaging, Inc., a cloud-based medical imaging solutions provider, today announced a commercial partnership to provide a new way for clinicians to connect with their colleagues and patients. This solution – called Tricefy™ – adds cloud-based image sharing, diagnostic collaboration, remote reviewing, archiving and Electronic Health Record... Read more

R-Pharm produces biological drugs in Yaroslavl with GE Healthcare's FlexFactory™ manufacturing platform

CHALFONT ST. GILES, UK and YAROSLAVL, RUSSIA – 22 September 2016 –  R-Pharm Group has opened an innovative biopharmaceutical production plant equipped with GE Healthcare’s FlexFactory™ manufacturing platform in Yaroslavl, Russia. R-Pharm’s FlexFactory will support the mass production of biologics and biosimilars focused on treating autoimmune diseases and cancer, and allowing for increased access to these... Read more

CE marked MACS® IVD Antibodies by Miltenyi Biotec – Compliant with IVDD and produced according to ISO 13485

BERGISCH GLADBACH, 19. September 2016 – Miltenyi Biotec has expanded its assortment of antibodies with a series of CE marked in vitro-diagnostic medical devices – MACS® IVD Antibodies. They can be used in both clinical flow cytometry and in the quality control of cellular products for translational research. The renowned biotech company from Bergisch Gladbach... Read more